Amgen (AMGN) — Stock Research & Financial Analysis

Amgen is a biotechnology company focused on oncology, inflammation, rare disease, and cardiovascular therapies supported by a broad commercial portfolio. Its profile depends on scale, competitive position, demand trends, and margin execution.